01
Assay Development
- P1Feasibility — needs assessment, regulatory review, cost projection & timeline
- P2Design & optimization — assay menus, technology acquisition, iterative testing
- P3Clinical validation — analytical performance, clinical utility, QA & reporting
The ability to quickly design and deploy high-quality assays is a core competency of successful labs. We will never sacrifice quality for speed — but our experience helps you avoid mistakes that delay deployment. You get to better, faster.
02Device Validation
Getting a new device or process into clinical use is difficult and time-consuming. We design and supervise functional, clinical, and analytical validations of molecular devices and processes — with an eye to both CAP accreditation and New York licensure. We oversee your staff, training them and helping prevent errors that waste time and money.
03NYSDOH Licensure & Permitting
Expert guidance through New York State licensure, permit applications, and CLEP requirements — structured to minimize deficiencies and accelerate approval timelines.
04Test Approval & Submissions
Preparation and submission of LDT approvals and test modification packets. Scientific and regulatory documentation that gets your technology investment into productive clinical use.
05CAP Accreditation
Guidance through the College of American Pathologists accreditation process — from gap assessment and policy development through checklist preparation and mock inspections. Ensuring your laboratory meets CAP standards for quality, compliance, and patient safety.
06PGx Result Interpretation
Recognized expertise in translating complex pharmacogenetic laboratory results into accurate clinical calls, with particular depth in CYP2D6. Consulting support for labs seeking interpretive guidance on challenging cases.
07Inspection Preparation
Systematic readiness planning for both CAP and NYSDOH CLEP inspections. Deficiency-prevention frameworks, mock inspections, staff preparation, and documentation review — so your team walks into inspection day with confidence.
08Due Diligence Inspections
Independent laboratory assessments for acquisitions, partnerships, or internal quality reviews. Objective evaluation of compliance posture, operational quality, and regulatory risk — giving stakeholders the information they need to make informed decisions.